Form 4: Deerfield Entities and James E. Flynn Report Bicara Therapeutics Holdings After IPO
SEC Form 4 Filing
James E. Flynn and related Deerfield entities report changes in beneficial ownership of Bicara Therapeutics Inc. common stock following the company's initial public offering.
Summary
- James E. Flynn, along with several Deerfield entities, filed a Form 4 reporting changes in beneficial ownership of Bicara Therapeutics Inc. (BCAX) securities on September 17, 2024.
- The filing reflects transactions related to the conversion of Series C Preferred Stock into common stock upon the closing of Bicara Therapeutics' IPO.
- The reporting entities include Deerfield Partners, L.P., Deerfield Private Design Fund V, L.P., Deerfield Mgmt V, L.P., Deerfield Mgmt, L.P., and Deerfield Management Company, L.P.
- These entities may be considered part of a 10% ownership group.
- The transactions include the conversion of 7,973,325 shares of Series C Preferred Stock into 862,587 shares of common stock for both Deerfield Partners, L.P. and Deerfield Private Design Fund V, L.P.
- Additionally, Deerfield Partners, L.P. and Deerfield Private Design Fund V, L.P. each purchased 35,000 shares of common stock at $18 per share.
- Following these transactions, Deerfield Partners, L.P. and Deerfield Private Design Fund V, L.P. each beneficially own 897,587 shares of common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the document primarily reports transactions related to an IPO, which is a standard financial event. There are no explicit positive or negative indicators.
Industry Context
Form 4 filings are standard practice after significant events like IPOs, providing transparency into insider transactions and ownership changes. This filing indicates the post-IPO holdings of a major investor, Deerfield, in Bicara Therapeutics.
Comparison to Industry Standards
- Form 4 filings are a standard regulatory requirement for reporting changes in beneficial ownership by insiders, aligning with SEC guidelines.
- Deerfield's investment activity is similar to other institutional investors who often adjust their holdings following an IPO.
Stakeholder Impact
- Shareholders are informed about the post-IPO ownership structure, particularly the holdings of significant investors like Deerfield.
- The filing provides transparency to the market regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 03/19/2024 | Date of Power of Attorney filing with regard to BiomX Inc. |
| 09/17/2024 | Date of earliest transaction and filing date of Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.